Evidence map›Paper›PMID 39201796›Full record

ArticleInternational journal of molecular sciences2024

Integrated Multi-Omics Analysis Reveals Mountain-Cultivated Ginseng Ameliorates Cold-Stimulated Steroid-Resistant Asthma by Regulating Interactions among Microbiota, Genes, and Metabolites.

Daohao Tang, Chao Wang, Hanlin Liu, Junzhe Wu, Luying Tan, Sihan Liu, Haoming Lv, Cuizhu Wang, Fang Wang, Jinping Liu

Erratum issuedAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Journal of ginseng research · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Daohao TangSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Chao WangCollege of Basic Medical Sciences, Jilin University, Changchun 130021, China.ORCID 0000-0002-0559-3015
Hanlin LiuSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Junzhe WuSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Luying TanSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Sihan LiuCollege of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, China.
Haoming LvSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Cuizhu WangSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.ORCID 0000-0002-0694-4059
Fang WangCollege of Basic Medical Sciences, Jilin University, Changchun 130021, China.ORCID 0000-0003-0871-3454
Jinping LiuSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.ORCID 0000-0003-4020-879X

Funding

Innovation Platform (base) and Talent Special Project 20210502005ZPKey Research and Development Program of Jilin Province 20230204038YY
6 · The paper itself

Abstract

Steroid-resistant asthma (SRA), resisting glucocorticoids such as dexamethasone (DEX), is a bottleneck in the treatment of asthma. It is characterized by a predominantly neutrophilic inflammatory subtype and is prone to developing into severe refractory asthma and fatal asthma. Currently, there is a lack of universally effective treatments for SRA. Moreover, since cold stimulation does increase the risk of asthma development and exacerbate asthma symptoms, the treatment of cold-stimulated SRA (CSRA) will face greater challenges. To find effective new methods to ameliorate CSRA, this study established a CSRA mouse model of allergic airway inflammation mimicking human asthma for the first time and evaluated the alleviating effects of 80% ethanol extract of mountain-cultivated ginseng (MCG) based on multi-omics analysis. The results indicate that cold stimulation indeed exacerbated the SRA-related symptoms in mice; the DEX individual treatment did not show a satisfactory effect; while the combination treatment of DEX and MCG could dose-dependently significantly enhance the lung function; reduce neutrophil aggregation; decrease the levels of LPS, IFN-γ, IL-1β, CXCL8, and IL-17; increase the level of IL-10; alleviate the inflammatory infiltration; and decrease the mucus secretion and the expression of MUC5AC. Moreover, the combination of DEX and high-dose (200 mg/kg) MCG could significantly increase the levels of tight junction proteins (TJs), regulate the disordered intestinal flora, increase the content of short-chain fatty acids (SCFAs), and regulate the abnormal gene profile and metabolic profile. Multi-omics integrated analysis showed that 7 gut microbes, 34 genes, 6 metabolites, and the involved 15 metabolic/signaling pathways were closely related to the pharmacological effects of combination therapy. In conclusion, integrated multi-omics profiling highlighted the benefits of MCG for CSRA mice by modulating the interactions of microbiota, genes, and metabolites. MCG shows great potential as a functional food in the adjuvant treatment of CSRA.

Indexed as

AsthmaDexamethasonePanaxPlant ExtractsAnimalsCold TemperatureCytokinesDisease Models, AnimalDrug ResistanceFemaleGastrointestinal MicrobiomeLungMetabolomicsMiceMice, Inbred BALB CMicrobiotaCytokinesDexamethasoneMucin 5ACPlant Extractscold-stimulatedmountain-cultivated ginsengmulti-omicssteroid-resistant asthmasynergistic effects

Identifiers

PMID39201796
PMCPMC11354367

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.